Fairmount Partners’ Post

Fairmount Partners is pleased to announce our latest Healthcare transaction: Federal Compliance Solutions, an IntegriChain company, a leading pharmaceutical advisory firm focused on government market access, pricing and value optimization, has been acquired by IntegriChain, a portfolio company of Nordic Capital. This transaction creates the industry’s deepest team of experts in government pricing and payer/provider contracting, areas that have simultaneously become more outsourced in pharma and the focus of significant regulatory and commercial changes.   Learn more here: https://lnkd.in/eq_Cr_55   The Fairmount Partners team supporting this transaction was Cornelius (Neal) McCarthy, R.C. Wainwright, Matt Wittig, and Ryan Remely.

Fairmount Partners is pleased to announce our latest Healthcare transaction: Think Research has sold BioPharma Services Inc., a leading full-service CRO specializing in early clinical trials, to HEALWELL AI.   Based out of Toronto, Ontario, BioPharma Services has an impressive record of successfully implementing bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed with approximately 250 pharmaceutical companies since its inception.   Learn more here: https://lnkd.in/ercnKT8m   The Fairmount Partners team supporting this transaction was Cornelius (Neal) McCarthy, Cecilia Vidaeus Gleason, Matt Wittig, and Ian Moore.

Fairmount Partners is pleased to announce our latest Industrial & Consumer transaction: S. H. Bell Company, a provider of cargo handling services to a diverse customer base in the upper Ohio River Valley, Chicago, and Baltimore regions, was acquired by Associated Terminals. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, Mihir Patel, and Brandon Johnson. Learn more here: https://lnkd.in/eXr664uZ

Join Fairmount Partners Managing Director Jonathan Smith and Director Bill Frame for the Delaware Valley Industrial Resource Center (DVIRC) Annual Manufacturing Executives Conference. Fairmount is an advocate of the region’s strong manufacturing base and is thrilled to partner with the DVIRC to bring together leading manufacturing CEOs for a wonderful day of education, networking, and, of course, golf. Register now: https://lnkd.in/ggvMUCfr

Fairmount Partners is pleased to announce our latest Industrial & Consumer transaction: Ballymore Safety Products, a leading designer and manufacturer of highly engineered material handling and vertical access safety products that facilitate the movement of people and goods throughout warehouses, factories, last-mile delivery, and retail locations, was acquired by One Equity Partners. Fairmount originally advised Ballymore in its sale to Graycliff Partners in 2021; with the sale, Graycliff fully exited the business after a successful three-year investment period. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, David Peslak, Ryan Remely, and Ian Moore. Learn more here: https://lnkd.in/eVeVJixn

Fairmount Partners’ Industrial & Consumer Practice Director, Bill Frame, will be attending MODEX 2024. Reach out to Bill directly to schedule a meeting: william.frame@fairmountpartners.com.   Register now: https://lnkd.in/gF4h3bEy

Fairmount Partners is pleased to announce that we have advised Kistler O'Brien Fire Protection on its sale to an industry-leading strategic acquirer. As the company embarks on its next phase of growth, KOB’s established leadership team, in concert with new ownership, will continue to drive the expansion of the company’s services offerings, financial and operational scale, and geographic footprint – all with the aim of serving its customers at an elevated level, with additional resources. The Fairmount team supporting this transaction was Jonathan Smith, Bill Frame, and Ryan Remely. Learn more here: https://lnkd.in/eVcrMQF6

Fairmount Partners Managing Director Andrew Brown shared his expert insights on staffing industry M&A with Staffing Industry Analysts. Read the article here: https://lnkd.in/gTUMksuC   For more thoughts on what to expect in the evolving market, contact Andy directly at andrew.brown@fairmountpartners.com.

We are pleased to present the CDMO Sector – Fairmount Partners 2023 Year in Review. In this review, we look back at notable news, scientific developments, and investments in the CDMO industry, all pointing to a stronger 2024 (and beyond) environment for M&A. Excitement around innovations in cell and gene therapy drug technologies and products, novel therapeutics involving oligos & peptides, and of course, advancements in artificial intelligence, are elevating demand for investments. Fairmount’s industry-leading pharma services group has a transaction portfolio of 180+ deals in 23 countries across North and South America, Australia, Asia and Europe. Within the CDMO and laboratory testing services sectors, we have closed 50+ deals for large services providers, small and mid-sized niche challengers, entrepreneurs and private equity. If you would like to receive a copy, please email cecilia.gleason@fairmountpartners.com.